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Abstract HI histones play an important role in regulating 
higher order structure of chromatin and are potential regulators 
of gene expression. H is  are phosphorylated, a modification which 
alters their interaction with DNA. We measured the abundance 
of three phospborylated HI  subtypes in mouse fibroblasts trans- 
formed by combinations of ras, myc and mutant p53 which differ 
in metastatic potential. We found that there is an increase in 
phosphorylation of HI subtypes in fibroblasts transformed with 
ras, myc and mutant p53. This increase was found to correlate 
with cellular transformation but not with induction of the meta- 
static phenotype. 
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1. Introduction 
Malignant progression is accompanied by multiple changes 
in the expression of cellular genes [1]. ras and several other 
oncogenes can induce the tumorigenic and metastatic pheno- 
types in permissive cell lines [2M], and therefore ras provides 
a very useful model of oncogene mediation of these processes. 
Further, current evidence suggests that ras participates in early 
stages of neoplastic development [5]. Some ras-induced changes 
in gene expression are likely due to regulatory changes in tran- 
scription factors [6-8]. However, alterations inchromatin struc- 
ture may also have roles in aberrant gene expression [9,10]. 
The H1 histones bind to linker DNA where the DNA enters 
and exits the nucleosome, and they compact the chromatin fiber 
into higher order structures [11]. H1 subtypes differing in pri- 
mary structure include Hla,  Hlb,  Hlc, Hld,  Hle, H i t  and H1 ° 
[12-14]. Posttranslational modifcation adds to heterogeneity n 
the H 1 s. Phosphorylation f H1 on serine and threonine in their 
amino and carboxyl terminal tails occurs in vivo and alters their 
interaction with DNA [11,15,16]. H 1 phosphorylation destabil- 
izes higher order chromatin structure which is thought o allow 
accessory factors to participate in replication, mitotic conden- 
sation, and gene activation [16]. 
ras-transformed murine NIH3T3 fibroblasts have a more 
decondensed chromatin structure compared to normal fibro- 
blasts [17]. Recently, we reported that murine 10Tl½ fib roblasts 
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transformed by one of several oncogenes utilizing the ras signal 
transduction pathway had both a decondensed nucleosomal 
structure and highly phosphorylated H1 subtypes [18]. In this 
study we compared the level of histone phosphorylation in cells 
transformed with combinations of ras, myc and mutant p53 
which differ in malignant potential [19]. We show that H1 is 
highly phosphorylated in these cell lines and that histone phos- 
phorylation correlates with cellular transformation but appears 
to be independent of metastatic potential. 
2. Materials and methods 
2.1. Cell lines and culture conditions 
Cell lines were grown in a humidified atmosphere containing 7% CO2 
in ~-minimal essential medium (~-MEM) (Gibco, Grand Island, NY) 
supplemented with penicillin G (100 units/ml) (Sigma, St. Louis, MO), 
streptomycin sulfate (100/zg/ml) (Sigma, St. Louis, MO) and 10% calf 
serum (Gibco). The mouse 10T½ fibroblast cell line obtained from 
American Type Culture Collection (ATCC) (Rockville, MD) was used 
to isolate cell lines expressing combinations of ras, myc and mutant p53. 
The derivation of these cell lines by transfection of 10T½ ceils with 
plasmids expressing ras, myc and mutant p53 has been previously de- 
scribed [19]. The transfectants u ed in this study and the oncogenes they 
express are R-2 (T24-Ha-ras), RM-5 (T24-Ha-ras, plus c-myc), RP-4 
and RP-6 (T24-Ha-ras plus the proline-193 mutant form of murine 
p53), and RMP-6 (T24-Ha-ras, c-myc plus the proline-193 p53 mutant). 
Cell cycle analysis was performed as described previously [18]. Malig- 
nant potential was determined by injecting single cell suspensions into 
the tail veins of syngeneic mice followed by examination of tumor 
formation in the lung 21 days later [19]. 
2.2. Isolation and analysis of ill 
Highly phosphorylated H1 was detected by immunoblotting proce- 
dures, using an antiserum raised in rabbits against phosphorylated H 1
from Tetrahymena [20]. The antibody reacts specifically with 
phosphorylated murine Hlb [18]. Perchloric acid extraction of HI, 
transfer to polyvinyl difluoride membranes and immunochemical detec- 
tion were done as previously described [18]. 
3. Results 
3.1. Phosphorylation of H1 in cell lines transformed with 
combinations of ras, myc and mutant p53 
H 1 histones undergo two types of phosphorylation. One type 
causes a reduction in electrophoretic mobility on SDS poly- 
acrylamide gels (c-phosphorylation), while the other does not 
affect mobility [14,18]. Murine H1 subtypes Hlc and H lb  un- 
dergo c-phosphorylation [18]. H1 subtypes isolated from mur- 
ine fibroblasts transformed with combinations of ras, myc and 
mutant p53 were electrophoretically separated in SDS poly- 
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A acrylamide gels. H1 subtypes H1 °, Hlc, Hld, Hle, and 
phosphorylated forms c-pH 1 b, c-pH Ic and pH 1 b were resolved 
in this gel system (Fig. 1A). Hid and Hie comigrated as a single 
band [I 8]. All of the ras-transformed cell lines had higher levels 
of c-pHlb and c-pHlc compared to 10T½ cells. The trans- 
formed fibroblasts had 1.6- to 2.7-fold higher levels of c-pHlb 
and 1.3 to 2.3-fold higher levels of c-pHlc (Table 1). The in- 
crease in these two phosphorylated species was found in all 
ras-transformed cell lines, and the presence of either myc or 
mutant p53 did not significantly alter this effect. 
3.2. Detection of phosphorylated HI histones with a specific 
antibody 
Recently an antiserum recognizing phosphorylated H1 but 
not unphosphorylated H1 has been described [20]. This anti- 
serum was raised against hyperphosphorylated H1 of 
Tetrahymena thermophila nd recognizes the phosphorylated 
form of murine Hlb (pHlb) which exhibits the same electro- 
phoretic mobility as its parent band [18]. Since the abundance 
of this phosphorylated band could not be determined by SDS 
gel electrophoresis alone, we employed immunoblot analysis 
with the pHlb antiserum to analyze this phosphorylated spe- 
cies. His isolated from cells transfected with ras, myc and 
mutant p53 were separated on SDS polyacrylamide g ls, and 
probed with the antiserum by immunoblotting. Sample loading 
onto the membranes was inspected by staining with india ink 
(Fig. 1B). The immunoblot shown in Fig. 1C demonstrates that 
the parental 10T1A cell line had a low level of phosphorylated 
H lb. However, cells transformed by combinations of ras, myc, 
and p53 contained 3.7- to 5.9-fold higher levels of this modified 
H1 subtype (Table 1). 
3.3. Cell cycle analysis 
The level of phosphorylation H 1 s varies considerably during 
the cell cycle [20,21]. In G1 phase, H1 generally contains ap- 
proximately 1 phosphorylated amino acid per molecule. How- 
ever, the level of phosphorylation rises to approximately 6 
residues per molecule for some H1 subtypes when cells enter 
M phase. H1 becomes dephosphorylated as cells exit M phase. 
A different cell cycle distribution for the transformed cell lines 
compared to that of the control cells may account for the 
changes in the levels of phosphorylated HI. Table 1 shows that 
there were no significant differences in the cell cycle distribu- 
tions of the transformed cells compared to 10T1/2 cells. Further- 
more, some of the transformed cells (R-2 and RP-6) had fewer 
Table 1 
Cell cycle distribution and level of phosphorylated hl histones of 10T½ 
murine fibroblasts ransformed with ras, myc and mutant p53 
Cell line Cell cycle phase Relative level of phosphoryl- 
(% distribution) ated H1 subtype 
G1 S G2/M c-pHlb pHlb c-pHlc 
10T½ 55 26 19 1.0 1.0 1.0 
R-2 61 26 13 1.6 3.7 1.3 
RM-5 54 25 21 2.2 4.8 1.6 
RP-4 49 31 19 2.6 2.9 1.7 
RP-6 50 33 17 2.6 6.7 1.8 
RMP-6 45 31 24 2.7 5.9 2.3 
H1 isolated from the oncogene-transformed and parental 10T½ cell 
lines were resolved on SDS 15% polyacrylamide g ls, and the level 
of phosphorylated H 1s on Coomassie blue-stained gel patterns or West- 
ern blots (shown in Fig. 1) was determined by densitometric analysis. 
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Fig. 1. Electrophoretic analysis of HI from fibroblasts ransfected with 
ras, myc, and mutant p53. H1 was extracted and separated by SDS 
polyacrylamide g lelectrophoresis. Two/tg of histone were loaded per 
lane. Gels were either stained with Coomassie blue (A), or transferred 
to polyvinyl difluoride membranes which were stained with india ink 
(B), and then probed with the antiserum against hyperphosphorylated 
H1 by immunoblotting (C) as described insection 2. In this figure, the 
same membrane used for immunoblotting was stained with india ink. 
Lanes are: (1) 10T½, (2) R-2, (3) RM-5, (4) RP-4, (5) RP-6, (6) RMP-6. 
c-pb and c-pc are the c-phosphorylated forms of histone H 1 b and Hlc, 
respectively, pbis the phosphorylated form of Hlb exhibiting the same 
mobility as the parent Hlb band. The remaining H1 subtypes are 
labeled as follows: H1 ° (o), Hlc (c), Hid (d), Hle (e). Hla is not 
detectable in this analysis [18]. 
G2/M cells than did the 10T½ cells, making it unlikely that the 
observed increase in H1 phosphorylation was secondary to 
altered cell cycle distributions. 
3.4. Correlation of i l l  phosphorylation with cellular 
transformation but not induction of the malignant phenotype 
We have previously shown that ras, myc and mutant p53 
cooperate in the induction of the metastatic phenotype in 10T½ 
cells [19]. This furnished us with an opportunity to test if in- 
creased phosphorylation f histone H1 might play a role in 
regulating the metastatic phenotype. It is evident that there is 
no correlation of any of these three phosphorylated histone 
subtypes with metastatic potential (Tables 1 and 2). In contrast 
all transfectants exhibited an increase. For example, the highly 
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metastatic RMP-6 cell line formed an average of 85.1 lung 
nodules when injected intravenously, whereas RP-6 cells did 
not metastasize in this assay, yet both cell lines had similar 
levels of all three phosphorylated H1 histone subtypes. In con- 
trast, all of the ras-transfected cell lines described in this study 
form tumors when injected subcutaneously (Table 2). There- 
fore, increased levels of c-pHlb, pHlb  and c-pHlc correlated 
well with cellular transformation but not with induction of the 
metastatic phenotype. 
4. Discussion 
The H1 histones are potential regulators of gene transcrip- 
tion [22]. Phosphorylation f H 1 alters its interaction with chro- 
matin and may be important in the transcriptional state of 
genes to which it is bound [15,16]. We observed in cells trans- 
formed by combinations of ras, myc and mutant p53 that there 
is an increased amount of the phosphorylated H1 subtypes 
c-pHlb, pHlb  and c-pHlc. This was observed in Coomassie 
Blue-stained gel patterns of histones resolved on SDS poly- 
acrylamide gels and using an antibody specific for 
phosphorylated H 1 b. The increase is unlikely to be a secondary 
effect of altered cell cyle distribution as some transformed cell 
lines, containing high levels of phosphorylated H1, contain 
fewer G2/M cells than the parental cell line. 
We have recently shown that cells transformed with onco- 
genes utilizing the ras signal transduction pathway have ele- 
vated levels of the phosphorylated H1 subtypes, and that these 
increases persist in the transformed cells blocked at the G1/S 
boundary with hydroxyurea [18]. This is consistent with ras 
activation leading to increased H1 phosphorylation and may 
explain the increase in chromatin decondensation previously 
observed in ras-transformed cells [17,18]. Furthermore, in- 
creased H1 phosphorylation i  G1/S might potentially be in- 
volved in regulating ene transcription. 
ras, myc and mutant p53 cooperate in the induction of the 
metastatic phenotype in murine fibroblasts [19]. This gave us 
an opportunity to test if altered histone phosphorylation might 
be important in the many changes in gene expression which 
occur during induction of the metastatic phenotype [1]. We 
Table 2 
Tumorigenic and malignant properties of 10T½ mouse fibroblasts 
transformed by combinations of ras, myc and mutant p53 
Cell line Gene Tumor latency* Metastatic potential b 
(days) (number of lung tumors) 
10T½ NA 0 
R-2 ras 15 0 
RM-5 ras, myc 11 0 
RP-4 ras, p53 12.8 11 
RP-6 ras, p53 10.2 0 
RMP-6 ras, myc, p53 7.4 85.1 
The properties of these cell lines have been previously described [19]. 
*Tumor latency was determined after subcutaneous injection of 1 x 105 
cells into immunocompetent C3H/HeN syngenic mice as previously 
described [19]. 10T1A cells are nontumorigenic [19,23]. 
b Metastatic potential was determined after intravenous injection of 
lxl05 cells into the tail veins of immunocompetent C3IM 
HeN syngeneic mice (five mice/clone) as described previously [19,23]. 
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found that there was no correlation between the level of c- 
pHlb,  pHlb  and c-pHlc and the metastatic potential of the 
transformed cell lines analyzed. In contrast, increased H 1 phos- 
phorylation was observed in all cell lines expressing the ras 
oncogene. This is consistent with our recent observations that 
stimulation of the ras pathway leads to increased H1 histone 
phosphorylation. I  10T1½ fibroblasts, which are rendered tu- 
morigenic by ras overexpression, wefound that H 1 phosphoryl- 
ation is associated with this phenotype. Our studies how that 
acquisition of high levels ofphosphorylated H1 is an early event 
in neoplastic development in this in vitro system. Thus, H1 
phosphorylation may affect he expression of genes involved in 
the loss of contact inhibition, growth factor dependence and 
growth control [1-4]. 
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